Literature DB >> 6571792

Extensive pulmonary infiltration by leukemic blast cells treated with irradiation.

A K Mangal, G H Growe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6571792      PMCID: PMC1875027     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Manifestations of acute leukemia in the parenchyma of the lung.

Authors:  D J NATHAN; M SANDERS
Journal:  N Engl J Med       Date:  1955-05-12       Impact factor: 91.245

2.  The pulmonary manifestations and complications of leukemia.

Authors:  E C KLATTE; J YARDLEY; E B SMITH; R ROHN; J A CAMPBELL
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1963-03

3.  Diffuse interstitial leukemic infiltration of the lungs producing the alveolar-capillary block syndrome. Report of a case, with studies of pulmonary function.

Authors:  M E RESNICK; R D BERKOWITZ; T RODMAN
Journal:  Am J Med       Date:  1961-07       Impact factor: 4.965

4.  Respiratory distress of hyperleukocytic granulocytic leukemias.

Authors:  J P Vernant; B Brun; P Mannoni; B Dreyfus
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

5.  Pulmonary leukemia in children presenting as diffuse interstitial pneumonia.

Authors:  R J Wells; R M Weetman; T V Ballantine; J L Grosfeld; R L Baehner
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

6.  Pulmonary complications of acute leukemia.

Authors:  G P Bodey; R D Powell; E M Hersh; A Yeterian; E J Freireich
Journal:  Cancer       Date:  1966-06       Impact factor: 6.860

7.  Diffuse pulmonary infiltrates in immunosuppressed patients. Prospective study of 80 cases.

Authors:  C Singer; D Armstrong; P P Rosen; P D Walzer; B Yu
Journal:  Am J Med       Date:  1979-01       Impact factor: 4.965

8.  Aggressive therapy in acute respiratory failure from leukemic pulmonary infiltrates.

Authors:  U B Prakash; M B Divertie; P M Banks
Journal:  Chest       Date:  1979-03       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.